Phase II prospective study of weekly topotecan and bevacizumab in platinum refractory ovarian or primary peritoneal cancer (OC)

✍ Scribed by K.F. McGonigle; H.G. Muntz; J. Vuky; P.J. Paley; D.S. Veljovich; H.J. Gray; T.W. Malpass

• Book ID: 113961741
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 77 KB
• Volume: 111
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2008.07.061